We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

83 hedge funds and large institutions have $78.5M invested in Surgalign Holdings, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 32 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less funds holding

Funds holding: 8883 (-5)

14% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 14

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

25% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 32

40% less capital invested

Capital invested by funds: $132M → $78.5M (-$53.2M)

Holders
83
Holders Change
-5
Holders Change %
-5.68%
% of All Funds
1.83%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
12
Increased
24
Reduced
32
Closed
14
Calls
$20K
Puts
Net Calls
+$20K
Net Calls Change
+$20K
Name Holding Trade Value Shares
Change
Change in
Stake
PCMI
1
Paradigm Capital Management Inc
New York
$10.5M +$394K +3,767 +2%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$8.34M +$181K +1,735 +1%
BlackRock
3
BlackRock
New York
$7.84M -$2.9M -27,778 -15%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$6.94M +$2.75M +26,312 +24%
KAM
5
Krensavage Asset Management
New York
$6.89M +$1.39M +13,294 +11%
KFO
6
Kopp Family Office
Minnesota
$6.17M -$356K -3,404 -3%
Vanguard Group
7
Vanguard Group
Pennsylvania
$5.93M +$462K +4,423 +4%
HM
8
HealthCor Management
New York
$3.69M
CLG
9
Cooperman Leon G
$2.72M +$3.05M +29,158 +122%
RA
10
Royce & Associates
New York
$2.15M +$779K +7,454 +22%
State Street
11
State Street
Massachusetts
$1.87M -$297K -2,837 -7%
HC
12
Hillman Company
Pennsylvania
$1.85M
Renaissance Technologies
13
Renaissance Technologies
New York
$1.76M -$1.04K -10 -0%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$1.55M +$367K +3,507 +13%
Victory Capital Management
15
Victory Capital Management
Texas
$1.46M +$1.22M +11,643 +70%
Northern Trust
16
Northern Trust
Illinois
$1.21M -$51.3K -491 -2%
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$728K -$1.76M -16,828 -54%
GF
18
Gabelli Funds
New York
$531K +$663K +6,348 +159%
GCIA
19
Gabelli & Co Investment Advisers
New York
$476K +$970K +9,281 New
N
20
Nuveen
North Carolina
$433K -$72.1K -690 -8%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$368K -$22.6K -216 -3%
JP Morgan Chase
22
JP Morgan Chase
New York
$359K +$320K +3,058 +77%
BCM
23
Bridgeway Capital Management
Texas
$344K -$423K -4,047 -38%
UBS Group
24
UBS Group
Switzerland
$245K -$184K -1,764 -27%
Wells Fargo
25
Wells Fargo
California
$241K +$53.5K +512 +12%

SRGA Hedge Fund Activity: Q1 2020 in Review

83 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q1 2020, worth a combined $78.5M — down 40% from $132M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of SRGA and 12 opened new positions — a net loss of 2 holders — while 32 trimmed existing stakes and 24 added.

The largest buyer was Cooperman Leon G, adding an estimated $3.05M. The largest seller was Rock Springs Capital Management, exiting entirely with an estimated $5.34M sold.

  • 83 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q1 2020, down from 88 in Q4 2019.
  • Funds reported $78.5M of Surgalign Holdings, Inc. Common Stock stock for Q1 2020, down 40% quarter-over-quarter.
  • 12 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q1 2020 and 14 closed out, a net change of -2 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q1 2020 was Cooperman Leon G, an estimated $3.05M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q1 2020 was Rock Springs Capital Management, an estimated $5.34M sold.

Based on aggregated 13F filings for Q1 2020.